Seven months after the FDA signed off on a reintroduction of Roche’s eye implant Susvimo, the U.S. regulator has broadened ...

Roche has secured a new FDA approval for its first companion diagnostic test aimed at identifying breast cancer patients with ...

Roche, who has made a name for himself with his work on iconic religious sites like Chartres cathedral in recent years, is ...

Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing ...

Roche (RHHBY) announced that the Food and Drug Administration has approved Susvimo 100 mg/mL for the treatment of diabetic macular edema, a ...

The FDA has approved an expanded label for Roche’s PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody test, which ...

An ongoing show at MAP, Bengaluru, highlights the transcultural exchange of ideas that resulted in the architectural ...

The duties will also cause self-inflicted economic damage and drive up inflation, warns Quantum Strategy's David Roche.

The wind farm is projected to have a 30-year lifespan. Roche said the company doesn’t intend to sell, and will be with the ...

The U.S.'s drug regulator has approved Roche's Susvimo drug for the treatment of diabetic macular edema, the leading cause of diabetes-related blindness, the pharmaceutical company said.

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...

A meeting was held to discuss the proposed Harvest Hills Wind Project in Whitman County, which plans to install 45 wind ...